10-QPeriod: Q3 FY2002

Elevance Health, Inc. Quarterly Report for Q3 Ended Sep 30, 2002

Filed November 4, 2002For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) reported strong financial performance for the quarter ending September 30, 2002. The company experienced significant revenue growth, driven by premium increases and membership expansion, notably bolstered by the acquisition of Trigon Healthcare, Inc. This strategic acquisition has expanded their market presence into the Southeast. Net income saw a substantial increase, reflecting improved operational performance and effective cost management. The company's balance sheet has strengthened, with a notable increase in total assets and shareholders' equity, demonstrating robust financial health. Investors should note the impact of the Trigon acquisition on reported figures, including increased goodwill and intangible assets, as well as the related debt financing. The company continues to navigate a dynamic healthcare landscape, evidenced by ongoing legal proceedings and its commitment to managing healthcare costs. Despite these challenges, Elevance Health demonstrates a clear growth trajectory and a solid financial foundation.

Key Highlights

  • 1Total operating revenue increased by 38% to $3.5 billion for the three months ended September 30, 2002, compared to $2.5 billion for the same period in 2001.
  • 2Net income grew significantly to $171.2 million for the quarter, a 54% increase from $111.5 million in the prior year period.
  • 3The acquisition of Trigon Healthcare, Inc. on July 31, 2002, significantly expanded the company's membership base and geographic reach, establishing a new Southeast segment.
  • 4Total assets grew substantially to $12.2 billion as of September 30, 2002, compared to $6.3 billion at December 31, 2001, largely due to the Trigon acquisition.
  • 5Shareholders' equity increased to $5.3 billion at September 30, 2002, from $2.1 billion at December 31, 2001, reflecting the impact of retained earnings and capital contributions.
  • 6The company successfully managed its benefit expense ratio, which decreased to 81.5% from 85.1% year-over-year, indicating improved underwriting results.
  • 7Total membership increased by 40% to 10.95 million, primarily driven by the Trigon acquisition, with organic growth of 7% in existing markets.

Frequently Asked Questions

The primary driver was the acquisition of Trigon Healthcare, Inc. on July 31, 2002. This acquisition significantly boosted premium revenue and membership, contributing to the substantial growth in both top-line revenue and net income. Additionally, improved underwriting results and effective cost management across existing segments also played a crucial role.

The acquisition of Trigon significantly increased total assets to $12.2 billion from $6.3 billion, primarily due to the recognition of $2.18 billion in goodwill and $1.17 billion in other intangible assets related to the acquisition. Shareholders' equity also saw a substantial rise, reaching $5.3 billion.

The company has demonstrated strong organic growth in its existing markets and expects continued integration benefits from the Trigon acquisition. However, potential challenges include managing rising healthcare costs, navigating a complex regulatory environment, and ongoing litigation. The company's management remains focused on operational efficiency and strategic growth initiatives.

Elevance Health is actively managing its cost of care through various strategies, including implementing three-tier drug programs to control pharmacy costs, encouraging procedures in the most appropriate settings to manage outpatient expenses, and negotiating provider contracts. The company is also focusing on utilization management and encouraging the use of generic drugs.